RxDoctor Payments Data

Daniel Coulston

Critical Care Medicine · Spokane, WANPI 1437178266

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 1 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Gilead. That places this record below the midpoint for critical care medicine clinicians in WA, where the typical reported total is $138.

$125in general payments, 2019–2025

Across 1 payment — averaging $125.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$125
$2,046,614in research payments, 2019–2025

Across 174 payments — averaging $11,762 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$808K
  • Grifols Therapeutics LLC$791K
  • Gilead$430K
  • AbbVie$13K
  • Boehringer Ingelheim$5K

What the payments were for

  • Food & beverage$125100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Gilead1$125

How this compares

$125 in reported general payments places this provider in the 45th percentile of 115 critical care medicine providers in Washington.

See all critical care medicine providers in Washington →

Other critical care medicine in Spokane

See the full list for Washington →

Where these figures come from

Is this you, or does something look wrong? →